IFNG and inflammation: Interleukin-5 (IL-5) contributes to eosinophil activation, while interleukin-17 (IL-17) and interferon-gamma (IFN-γ) from T-helper 1 (Th1) and T-helper 17 (Th17) cells drive chronic inflammation and further damage to the skin.